| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/24/2014 | WO2013141833A3 Genetic based health management apparatus and methods |
| 04/24/2014 | WO2013122611A3 New method for decontamination and processing of clinical specimens from a patient |
| 04/24/2014 | WO2012125848A3 A method for comprehensive sequence analysis using deep sequencing technology |
| 04/24/2014 | WO2012112720A3 Methods for predicting cardiovascular risks and responsiveness to statin therapy using snps |
| 04/24/2014 | WO2012109466A3 Long non-coding rna spry4-it1 as a diagnostic and therapeutic agent |
| 04/24/2014 | WO2012106674A3 Using a cytokine signature to diagnose disease or infection |
| 04/24/2014 | WO2012075318A3 Fn1 and alk gene translocations in cancer and alk kinase expression in ovarian cancer |
| 04/24/2014 | WO2012065100A3 Cxcr4 as a susceptibility locus in juvenile idiopathic arthritis (jia) and methods of use thereof for the treatment and diagnosis of the same |
| 04/24/2014 | WO2012044933A8 B and t lymphocyte attenuator marker for use in adoptive t-cell therapy |
| 04/24/2014 | US20140115741 F. oxysporum f.sp. melonis race 1,2-resistant melons |
| 04/24/2014 | US20140115735 Cucurbita plant resistant to potyvirus |
| 04/24/2014 | US20140115730 Apparatuses and Methods for Evaluating and Sorting Pollen and Plants |
| 04/24/2014 | US20140114579 Hla typing using selective amplification and sequencing |
| 04/24/2014 | US20140113978 Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof |
| 04/24/2014 | US20140113972 Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status |
| 04/24/2014 | US20140113954 The Micrornaome |
| 04/24/2014 | US20140113952 Transposable elements, tdp-43, and neurodegenerative disorders |
| 04/24/2014 | US20140113913 Mcl-1 as a therapeutic target in scffbw7 deficient neoplasm |
| 04/24/2014 | US20140113876 Biomarkers for assessing treatment of sialic acid deficiency diseases and conditions |
| 04/24/2014 | US20140113839 Methods of Making Oligonucleotide Probes |
| 04/24/2014 | US20140113837 System and method for determining individualized medical intervention for a disease state |
| 04/24/2014 | US20140113829 Systems and methods of selecting combinatorial coordinately dysregulated biomarker subnetworks |
| 04/24/2014 | US20140113364 Cell culture device |
| 04/24/2014 | US20140113357 Remote chemical assay system |
| 04/24/2014 | US20140113333 Whole Transcriptome Sequencing |
| 04/24/2014 | US20140113327 Biochemical sensor for quantitative simultaneous multi-species bacteria detection in situ |
| 04/24/2014 | US20140113326 Kit for detecting biofilms |
| 04/24/2014 | US20140113325 Use of fluorescent saccharide-based derivative |
| 04/24/2014 | US20140113322 Supramolecular nanobeacon imaging agents as protease sensors |
| 04/24/2014 | US20140113321 Identification of cellulolytic microorganism contamination in food and other materials |
| 04/24/2014 | US20140113313 Method of diagnosing adolescent idiopathic scoliosis |
| 04/24/2014 | US20140113312 Classification of kinase inhibitors using nonlinear optical techniques |
| 04/24/2014 | US20140113303 Chemical Coating of Microwell for Electrochemical Detection Device |
| 04/24/2014 | US20140113302 Methods for sequencing, amplification and detection of nucleic acids comprising internally labelled primer |
| 04/24/2014 | US20140113301 Detection of saxitoxin-producing dinoflagellates |
| 04/24/2014 | US20140113300 Methods for analyzing dna |
| 04/24/2014 | US20140113299 Inhibition-resistant polymerases |
| 04/24/2014 | US20140113297 Gene expression predictors of cancer prognosis |
| 04/24/2014 | US20140113296 Addition of an adaptor by invasive cleavage |
| 04/24/2014 | US20140113295 Apparatus for isolation of extracellular vesicles comprising porous polymer monolith microfilter |
| 04/24/2014 | US20140113293 Method for the detection of egfr mutations in blood samples |
| 04/24/2014 | US20140113292 Detecting nucleic acid |
| 04/24/2014 | US20140113291 Salt-tolerant DNA polymerases |
| 04/24/2014 | US20140113290 Aberrant methylation of c6orf150 dna sequences in human colorectal cancer |
| 04/24/2014 | US20140113289 Compositions and methods to detect legionella pneumophila nucleic acid |
| 04/24/2014 | US20140113288 Methods of identifying risk of preeclampsia and pregnancy-related disorders |
| 04/24/2014 | US20140113287 Base sequence analysis method, base sequence analysis apparatus, and base sequence analysis program |
| 04/24/2014 | US20140113286 Epigenomic Markers of Cancer Metastasis |
| 04/24/2014 | US20140113285 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
| 04/24/2014 | US20140113284 Differential detection and quantification of oxalobacter |
| 04/24/2014 | US20140113282 Labelled nucleotides |
| 04/24/2014 | US20140113281 Methods, Systems, and Computer Readable Media for Repeat Sequencing |
| 04/24/2014 | US20140113279 Method for Preventing High Molecular Weight Products During Amplification |
| 04/24/2014 | US20140113278 Sample processing apparatus and methods |
| 04/24/2014 | US20140113277 Ultrasonic biological sample analysis apparatus and methods |
| 04/24/2014 | US20140113006 Methods of determining whether the wnt signaling pathway is upregulated in a tumor |
| 04/24/2014 | US20140112944 Compositions and methods for treating cancer |
| 04/24/2014 | US20140112917 Diagnostic and therapeutic methods and compositions involving pten and breast cancer |
| 04/24/2014 | US20140112913 Methods of prognosing and administering treatment for inflammatory disorders |
| 04/24/2014 | US20140112871 Nucleic acid probes and methods of using the same |
| 04/24/2014 | DE102012219156A1 Integriertes mikrofluidisches bauteil zur anreicherung und extraktion biologischer zellbestandteile Integrated microfluidic component for enrichment and extraction of biological cell consisted share |
| 04/24/2014 | DE102012020496A1 Invitro diagnosis and/or early detection of neurofibromatosis type 1 and/or neurofibromatosis type 1-associated tumor from sample of a patient for treating the patient with the tumor, comprises detecting protein or its fragment in sample |
| 04/24/2014 | DE102011052604B4 Vorrichtung und Verfahren zur Verbesserung der Qualität von Trink- und/oder Brauchwasser Apparatus and method for improving the quality of drinking water and / or hot water |
| 04/23/2014 | EP2722668A1 High throughput screening of ion channels |
| 04/23/2014 | EP2722424A2 Methods of modulating thrombocytopenia and modified transgenic pigs |
| 04/23/2014 | EP2722404A1 Methods of predicting methotrextrate efficacy and toxicity |
| 04/23/2014 | EP2722403A1 Method for preventing high molecular weight products during amplification |
| 04/23/2014 | EP2722402A1 Method for separating, detecting or enriching different DNA species |
| 04/23/2014 | EP2722401A1 Addition of an adaptor by invasive cleavage |
| 04/23/2014 | EP2722400A2 Methods of using biomarkers |
| 04/23/2014 | EP2722399A1 Method for preventing high molecular weight products during amplification |
| 04/23/2014 | EP2722398A1 Dual probe assay for the detection of HCV |
| 04/23/2014 | EP2722397A1 Dual probe assay for the detection of heterogeneous amplicon populations |
| 04/23/2014 | EP2722396A1 Method for measuring glycosylated hemoglobin, measurement reagent, and measurement kit |
| 04/23/2014 | EP2722395A1 Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
| 04/23/2014 | EP2722388A1 Nucleic acid probe for assaying nucleic acids |
| 04/23/2014 | EP2721183A2 Reagents and methods for detecting hcv |
| 04/23/2014 | EP2721182A1 Automated size selection of nucleic acids |
| 04/23/2014 | EP2721181A2 Methods and materials for assessing allelic imbalance |
| 04/23/2014 | EP2721180A1 Genetic variants for predicting risk of breast cancer |
| 04/23/2014 | EP2721179A2 Biomarker compositions and methods |
| 04/23/2014 | EP2721178A1 Method for the prognosis of breast cancer based on the expression of the gene pin1 in combination with mutations in the gene tp53 |
| 04/23/2014 | EP2721177A1 Flat-field imaging system and methods of use |
| 04/23/2014 | EP2721176A2 Signatures for predicting the survivability of myelodysplastic syndrome subjects |
| 04/23/2014 | EP2721175A1 Compositions and methods for diagnosing and monitoring hyperthyroidism in a feline |
| 04/23/2014 | EP2721174A1 Method for predicting the clinical response to chemotherapy in a subject with cancer |
| 04/23/2014 | EP2721173A1 Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals |
| 04/23/2014 | EP2721172A2 Thromboembolic disease |
| 04/23/2014 | EP2721171A1 Discrimination of blood type variants |
| 04/23/2014 | EP2721170A2 Compositions and methods for detection of cronobacter spp. and cronobacter species and strains |
| 04/23/2014 | EP2721169A2 Modulation of tissue transglutaminase activation in disease |
| 04/23/2014 | EP2721155A2 Identifying markers of caloric restriction and caloric restriction mimetics |
| 04/23/2014 | EP2721145A1 High through-put screening in skin fibroblasts with an alpha-synuclein triplication |
| 04/23/2014 | EP2721054A1 Modified antibiotic peptides having variable systemic release |
| 04/23/2014 | EP2720720A1 Combination therapy to prevent dcis formation and progression to breast cancer |
| 04/23/2014 | EP2720703A1 Methods for increasing insulin sensitivity and treating diabetes |
| 04/23/2014 | CN103748238A Detection of prame gene expression in cancer |
| 04/23/2014 | CN103748237A Prognostic methodology |
| 04/23/2014 | CN103748236A Safe sequencing system |
| 04/23/2014 | CN103748235A Detection of saxitoxin-producing dinoflagellates |